中性粒细胞与淋巴细胞比值在高危皮肤鳞状细胞癌预后中的价值:单中心回顾性队列研究
该单中心回顾性队列纳入420例接受手术切除的高危皮肤鳞状细胞癌患者,评估术前中性粒细胞与淋巴细胞比值(NLR)的预后价值。NLR以连续变量及ROC衍生的切点≥3分析,Fine-Gray模型处理竞争死亡风险,Cox回归分析总生存。结果显示NLR≥3独立关联无复发生存、总生存及其他cSCC特异性终点,提示术前NLR可作为低成本补充生物标志物辅助风险分层。
要点
- 术前NLR≥3与高危cSCC无复发生存、总生存及cSCC特异性终点独立相关。
- NLR可作为低成本补充标志物,辅助现有风险分层,但单独判别能力有限。
核心结论
- 术前NLR是一种低成本补充生物标志物,独立关联高危cSCC的不良结局,可能补充当前风险分层。
研究设计与样本
- 单中心回顾性队列研究,纳入420例接受手术切除且术前40天内完成全血细胞计数的高危cSCC患者。
- NLR以连续变量及ROC衍生切点≥3分析;cSCC特异性终点采用Fine-Gray模型处理竞争死亡风险,总生存采用Cox回归。
主要发现
- NLR≥3独立关联所有其他cSCC特异性终点。
关键数值与推荐
- NLR切点≥3(由ROC衍生,最佳值2.97取整),用于定义高风险组。
临床怎么用
- 在高危cSCC患者术前可计算NLR,若≥3提示预后较差,可辅助风险分层。
- NLR应作为现有预后因素的补充,而非单独决策依据,因其单独判别能力有限。
局限性
- 回顾性单中心设计。
- NLR单独判别能力有限(AUC 0.622)。
- 可能存在未记录的炎症性疾病导致的残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. Although prognosis is generally favorable, a subset of tumors behaves aggressively. Most established prognostic factors are defined after excision, limiting preoperative risk assessment. The neutrophil-to-lymphocyte ratio (NLR) is an accessible marker of systemic inflammation, but its prognostic value in cSCC remains insufficiently defined. OBJECTIVE: To evaluate the prognostic utility of preoperative NLR in patients with high-risk cSCC. METHODS: We conducted a single-center retrospective cohort study including 420 patients with high-risk cSCC who underwent surgical excision and had a complete blood count within 40 days before surgery. NLR was analyzed continuously and using a receiver operating characteristic-derived cut-off of ≥3. Fine-Gray models addressed competing mortality for cSCC-specific endpoints, whereas Cox regression was used for overall survival. RESULTS: The optimal NLR cut-off for recurrence-free survival was 2.97, rounded to 3 (area under the receiver operating characteristic curve = 0.622 [0.554-0.690]). NLR ≥3 was independently associated with recurrence-free survival (subdistribution hazard ratios = 2.43 [1.62-3.66], P <.001) overall survival (hazard ratio = 1.49 [1.14-1.94], P = .003), and all other cSCC-specific endpoints. LIMITATIONS: Retrospective single-center design, modest discriminatory ability of NLR alone, and possible residual confounding from unrecorded inflammatory conditions. CONCLUSION: Preoperative NLR is a low-cost complementary biomarker independently associated with poor outcomes in high-risk cSCC and may complement current risk stratification.
引用
- Cardona-Machado C, Felices B, Rodríguez-Conde S, et al. Usefulness of neutrophil-to-lymphocyte ratio in the prognosis of cutaneous squamous cell carcinoma: A single-center retrospective cohort study. J Am Acad Dermatol. 2026. PMID: 42822768. doi:10.1016/j.jaad.2026.09.097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。